IBDEI14X ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20022,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,20023,0)
 ;;=496.^^105^1241^20
 ;;^UTILITY(U,$J,358.3,20023,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20023,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,20023,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,20023,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,20024,0)
 ;;=414.01^^105^1241^23
 ;;^UTILITY(U,$J,358.3,20024,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20024,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,20024,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,20024,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,20025,0)
 ;;=311.^^105^1241^25
 ;;^UTILITY(U,$J,358.3,20025,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20025,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,20025,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,20025,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,20026,0)
 ;;=250.01^^105^1241^26
 ;;^UTILITY(U,$J,358.3,20026,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20026,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,20026,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,20026,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,20027,0)
 ;;=250.00^^105^1241^27
 ;;^UTILITY(U,$J,358.3,20027,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20027,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,20027,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,20027,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,20028,0)
 ;;=305.90^^105^1241^29
 ;;^UTILITY(U,$J,358.3,20028,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20028,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,20028,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,20028,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,20029,0)
 ;;=305.93^^105^1241^28
 ;;^UTILITY(U,$J,358.3,20029,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20029,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,20029,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,20029,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,20030,0)
 ;;=796.2^^105^1241^33
 ;;^UTILITY(U,$J,358.3,20030,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20030,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,20030,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,20030,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,20031,0)
 ;;=607.84^^105^1241^35
 ;;^UTILITY(U,$J,358.3,20031,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20031,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,20031,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,20031,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,20032,0)
 ;;=530.81^^105^1241^36
 ;;^UTILITY(U,$J,358.3,20032,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20032,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,20032,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,20032,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,20033,0)
 ;;=389.9^^105^1241^39
 ;;^UTILITY(U,$J,358.3,20033,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20033,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,20033,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,20033,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,20034,0)
 ;;=784.0^^105^1241^38
 ;;^UTILITY(U,$J,358.3,20034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20034,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,20034,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,20034,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,20035,0)
 ;;=070.54^^105^1241^40
 ;;^UTILITY(U,$J,358.3,20035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20035,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,20035,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,20035,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,20036,0)
 ;;=272.4^^105^1241^41
 ;;^UTILITY(U,$J,358.3,20036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20036,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,20036,1,5,0)
 ;;=5^Hyperlipidemia
 ;;
 ;;$END ROU IBDEI14X
